What You Need to Know Ahead of Apollo Global Management's Earnings Release
Ahead of the event, analysts expect APO to report a profit of $1.75 per share on a diluted basis, up 22.4% from $1.43 per share in the year-ago quarter. The company missed the consensus estimates in three of the last four quarters while beating the forecast on another occasion.
More News from Barchart
It's Never 'Happened in the History of Tech to Any Company Before': OpenAI's Sam Altman Says ChatGPT is Growing at an Unprecedented Rate
Ditch 'Basic' Nvidia and Buy This 'Unique' Chip Stock Instead
Tesla Earnings, Powell Speech and Other Can't Miss Items this Week
Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines.
For the full year, analysts expect APO to report EPS of $7.20, up 9.3% from $6.59 in fiscal 2024. Its EPS is expected to rise 20.8% year-over-year to $8.70 in fiscal 2026.
APO stock has outperformed the S&P 500 Index's ($SPX) 13.6% gains over the past 52 weeks, with shares up 26.3% during this period. Similarly, it outperformed the Financial Select Sector SPDR Fund's (XLF) 21.4% gains over the same time frame.
APO is partnering with major banks, including JPMorgan Chase & Co. (JPM) and The Goldman Sachs Group, Inc. (GS), to increase liquidity in the private credit market. This collaboration aims to actively syndicate and trade investment-grade private debt, allowing for faster origination of larger loans. By enhancing liquidity and accessibility, APO is poised to attract both institutional and individual investors, driving growth in the private credit market. This initiative is part of APO's strategy to expand its credit trading footprint and solidify its position as a key player in shaping the future of private credit trading.
On May 2, APO shares closed down more than 1% after the company reported its Q1 results. Its revenue stood at $5.5 billion, down 21.2% year-over-year. The company's adjusted EPS increased 5.8% year-over-year to $1.82.
Analysts' consensus opinion on APO stock is bullish, with an overall 'Strong Buy' rating. Out of 21 analysts covering the stock, 16 advise a 'Strong Buy' rating, one suggests a 'Moderate Buy,' and four give a 'Hold.' APO's average analyst price target is $164.63, indicating a potential upside of 8.3% from the current levels.
On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Oversold Abbott Laboratories (ABT) Could Offer a Healthy Dividend Opportunity
Abbott Laboratories (NYSE:ABT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. The company reported strong earnings in the second quarter of 2025. It posted revenue of $11.1 billion, which showed a 7.37% growth on a YoY basis. The company reported GAAP diluted earnings per share of $1.01, while adjusted diluted EPS came in at $1.26. Gross margin was 52.7% of sales on a reported basis, with the adjusted gross margin reaching 57.0%, representing a 100 basis point improvement. Abbott Laboratories (NYSE:ABT) reiterated its guidance and pointed to strong momentum in both its devices and nutrition segments as it moves into the second half of the year. A brief valuation analysis, based on a five-year free cash flow CAGR of 5.74%— calculated using 6% growth in operating cash flow and 2% growth in capital expenditures— suggests that the current share price of $120.51 offers promising return potential. On June 13, Abbott Laboratories (NYSE:ABT) declared a quarterly dividend of $0.59 per share, which was in line with its previous dividend. This was the company's 406th consecutive quarterly dividend. In addition, ABT has raised its payouts for 53 years in a row. The stock offers a quarterly dividend of 1.86%, as of July 25. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
7 minutes ago
- Yahoo
Why Oversold Lockheed Martin (LMT) Could Be a Defensive Dividend Powerhouse
Lockheed Martin Corporation (NYSE:LMT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. Two fighter jets in flight, highlighting the technology and experience of the companies combat aircraft. The company has long held a leading position in the US aerospace and defense sector. It supplies advanced technologies and services to the US Department of Defense, NASA, and various international government agencies. Its space division is one of the company's four key segments. For investors looking for a diversified and established aerospace company with ties to the growing space industry, Lockheed Martin may be a strong addition to their portfolio. Lockheed Martin Corporation (NYSE:LMT) maintained a strong cash position, reinforcing its appeal as a reliable dividend investment. In the most recent quarter, the company reported an operating cash flow of $201 million. It also returned $1.3 billion to investors through dividends and share repurchases. On June 26, Lockheed Martin Corporation (NYSE:LMT) declared a quarterly dividend of $3.30 per share, which was consistent with its previous dividend. The company has been rewarding shareholders with growing dividends for the past 22 years. The stock offers a dividend yield of 3.11%, as of July 25. While we acknowledge the potential of LMT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
7 minutes ago
- Yahoo
Oversold but Not Overlooked: Why FactSet (FDS) Deserves a Second Look
FactSet Research Systems Inc. (NYSE:FDS) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. An investment banker consulting with a customer on their portfolio in a professional setting. The company's third-quarter earnings demonstrated the successful implementation of its enterprise solution strategy. With a strong pipeline and growing momentum, it appeared well-positioned to close the fiscal year on a solid note. FactSet Research Systems Inc. (NYSE:FDS) reported revenue of $585.5 million in fiscal Q3 2025, up 6% from the same period last year. The revenue also beat analysts' estimates by $4.62 million. As of May 31, 2025, the company's Annual Subscription Value (ASV) reached $2.33 billion, an increase from $2.2 billion recorded on the same date in 2024. On an organic basis, ASV stood at $2.3 billion, reflecting a year-over-year growth of 4.5%, or $98.5 million. FactSet Research Systems Inc. (NYSE:FDS)'s cash position also remained strong. The company reported an operating cash flow of $253.8 million and its free cash flow was $228.6 million, both up by 6.5% and 5.4%, respectively. In addition, it returned $41.6 million to shareholders through dividends, which showed the commitment toward its investors. FactSet Research Systems Inc. (NYSE:FDS) currently offers a quarterly dividend of $1.10 per share, having raised it by 6% in May 2025. This was the company's 26th consecutive year of dividend growth. The stock has a dividend yield of 1.05%, as of July 25. While we acknowledge the potential of FDS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
